Products for Research Use Only
RegisterLogin

Revumenib (SNDX-5613)

CAT: 0957-S8996-100mgSize: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-S8996-100mgSize:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2169919-21-3
Target
MLL
Applications
Epigenetics
Smiles
CCN (C (C) C) C (=O) C1=C (OC2=CN=CN=C2N3CC4 (CCN (CC4) CC5CCC (CC5) N[S] (=O) (=O) CC) C3) C=CC (=C1) F
Molecular Formula
C32H47FN6O4S
Additionnal Information
Revumenib (SNDX-5613) is a potent and selective inhibitor of menin-MLL binding with a Ki of 0.15 nM. SNDX-5613 shows anti-proliferative activity against multiple cell lines harboring MLLr translocations (MV4;11, RS4;11, MOLM-13, KOPN-8) with IC50 values ranging from 10-20 nM.
Storage Conditions
3 years -20°C powder

Related Products

CatalogName
F5098-01SND1 Antibody [J10N22]
A02602-3Anti-SND1 Antibody Picoband®
E1743-5mgVX-561 (CTP-656)
E1743-01VX-561 (CTP-656)
E1743-25mgVX-561 (CTP-656)
M02602-2Anti-SND1 Antibody Picoband® (monoclonal, 6G3B4)
M02602-1Anti-SND1 Antibody Picoband® (monoclonal, 5F5E9)

Alternative Products

CatalogName
S8996-5mgRevumenib (SNDX-5613)
C21534-1gSNDX-5613 (Revumenib)
A22526-2Revumenib (SNDX-5613) 2mg
A22526-1Revumenib (SNDX-5613) 1mg
A22526-25Revumenib (SNDX-5613) 25mg
A22526-10mM-DRevumenib (SNDX-5613) 10mM * 1mL in DMSO
MBS5753933SNDX-5613
A22526-5SNDX-5613 5mg
A22526-50SNDX-5613 50mg
A22526-10SNDX-5613 10mg

Popular Products